Glargine and lispro: two cases of mistaken identity.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Diabetes Care

• Publication date

  2002-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIACARE.25.2.404PMID 11815523
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin Glargine

  2012cited by this paper
• Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

  2000cited by this paper
• Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

  2000cited by this paper
• Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

  2000cited by this paper
• Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.

  2000cited by this paper

• A COMPARATIVE STUDY AND ASSESSMENT OF THE QUALITY OF LIFE OF TYPE 1 DIABETES PATIENTS ON MDI AND CSII THERAPIES IN INDIA

  2015cites this paper
• Executive Agency for Health and Consumers

  2014cites this paper
• Utilisation de l’insuline en établissement de santé universitaire mère-enfant : Une analyse des modes de défaillance au moyen d’un diagramme d’Ishikawa

  2014cites this paper
• Hypoglycemia caused by Insulin

  2011cites this paper
• Prescribing errors in diabetes

  2009cites this paper
• Safety, simplicity and convenience of a modified prefilled insulin pen.

  2008cites this paper
• Safety, simplicity and convenience of a modified prefilled insulin pen

  2008cites this paper
• Dose accuracy and injection force dynamics of a novel disposable insulin pen

  2007cites this paper
• Type 1 Diabetes in Children, Adolescents, and Young Adults: How to Become an Expert on Your Own Diabetes

  2006cites this paper
• Mortality of percutaneous endoscopic Mortality of percutaneous endoscopic Mortality of percutaneous endoscopic Mortality of percutaneous endoscopic Mortality of percutaneous endoscopic gastrostomy in the UK gastrostomy in the UK gastrostomy in the UK gastrostomy in the UK gastrostomy in the UK

  2005cites this paper
• Medication Errors Involving "L Insulins"

  2005cites this paper
• Mortality of percutaneous endoscopic gastrostomy in the UK.

  2005cites this paper
• Detection, Prevention, and Treatment of Hypoglycemia in the Hospital

  2005cites this paper
• Management of diabetes and hyperglycemia in hospitals.

  2004cites this paper
• Management of hyperglycemia in the hospitalized podiatric medical patient.

  2004cites this paper
• Insulin glargine: a new once-daily basal insulin for the management of type 1 and type 2 diabetes mellitus.

  2003cites this paper
• Insulin, glucagon, and hypoglycemic drugs

  2003cites this paper
• Current Awareness

  2002cites this paper
• Increase in serum uric acid is selectively associated with stroke in type 2 diabetes.

  2002cites this paper
• Insulin confusion: an observation.

  2002cites this paper
• Reducing mistakes in patient administration of glargine and lispro.

  2002cites this paper
• Errors of Insulin Commission

  2002cites this paper
• New and future diabetes therapies: are they safe during pregnancy?

  2002cites this paper